87.58 USD
-1.78
1.99%
Updated May 20, 3:07 PM EDT
1 day
-1.99%
5 days
-0.44%
1 month
-4.16%
3 months
-2.22%
6 months
2.43%
Year to date
4.95%
1 year
-0.59%
5 years
41.88%
10 years
50.90%
 

About: Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Employees: 25,599

0
Funds holding %
of 7,202 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

25% more funds holding in top 10

Funds holding in top 10: 12 [Q4 2024] → 15 (+3) [Q1 2025]

5% more capital invested

Capital invested by funds: $22.2B [Q4 2024] → $23.4B (+$1.17B) [Q1 2025]

9% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 70

2% less funds holding

Funds holding: 645 [Q4 2024] → 633 (-12) [Q1 2025]

5.38% less ownership

Funds ownership: 53.07% [Q4 2024] → 47.69% (-5.38%) [Q1 2025]

11% less repeat investments, than reductions

Existing positions increased: 193 | Existing positions reduced: 217

33% less call options, than puts

Call options by funds: $226M | Put options by funds: $340M

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$108
23%
upside
Avg. target
$113
28%
upside
High target
$120
37%
upside

4 analyst ratings

positive
100%
neutral
0%
negative
0%
Needham
David Saxon
26%upside
$110
Buy
Reiterated
14 May 2025
Keybanc
Brett Fishbin
28%upside
$112
Overweight
Maintained
31 Mar 2025
Mizuho
Anthony Petrone
37%upside
$120
Outperform
Maintained
28 Mar 2025
Baird
Jeff Johnson
23%upside
$108
Outperform
Maintained
27 Feb 2025

Financial journalist opinion

Based on 8 articles about ALC published over the past 30 days

Neutral
Seeking Alpha
6 days ago
Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript
Alcon Inc. (NYSE:ALC ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Jack Reynolds-Clark - RBC Capital Markets Graham Doyle - UBS Ryan Zimmerman - BTIG David Saxon - Needham & Company Larry Biegelsen - Wells Fargo Patrick Wood - Morgan Stanley Anthony Petrone - Mizuho Group Tom Stephan - Stifel Brett Fishbin - KeyBanc Capital Markets Young Li - Jefferies Jeff Johnson - Baird David Adlington - JPMorgan Operator Greetings, and welcome to the Alcon First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
6 days ago
Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered
ALC ends the first quarter of 2025 on a disappointing note.
Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered
Negative
Benzinga
6 days ago
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday.
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Positive
Zacks Investment Research
6 days ago
Alcon (ALC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alcon (ALC) Reports Q1 Earnings: What Key Metrics Have to Say
Neutral
Business Wire
6 days ago
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
GENEVA--(BUSINESS WIRE)--Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS.
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
Neutral
Zacks Investment Research
1 week ago
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Alcon (ALC) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Neutral
Business Wire
1 week ago
Alcon Announces Results of 2025 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2025 Annual General Meeting.
Alcon Announces Results of 2025 Annual General Meeting
Neutral
Business Wire
3 weeks ago
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
GENEVA--(BUSINESS WIRE)--Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS.
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
Neutral
Business Wire
1 month ago
Alcon Publishes Agenda for 2025 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.
Alcon Publishes Agenda for 2025 Annual General Meeting
Neutral
Business Wire
1 month ago
Alcon Publishes Agenda for 2025 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2025 Annual General Meeting.
Alcon Publishes Agenda for 2025 Annual General Meeting
Charts implemented using Lightweight Charts™